{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:05:54Z","timestamp":1783634754205,"version":"3.55.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["765549"],"award-info":[{"award-number":["765549"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["project \u2018M-GATE\u2019"],"award-info":[{"award-number":["project \u2018M-GATE\u2019"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The two main histopathological hallmarks that characterize Alzheimer\u2019s Disease are the presence of amyloid plaques and neurofibrillary tangles. One of the current approaches to studying the consequences of amyloid pathology relies on the usage of transgenic animal models that incorporate the mutant humanized form of the amyloid precursor protein (hAPP), with animal models progressively developing amyloid pathology as they age. However, these mice models generally overexpress the hAPP protein to facilitate the development of amyloid pathology, which has been suggested to elicit pathological and neuropathological changes unrelated to amyloid pathology. In this current study, we characterized APP knock-in (APP-KI) animals, that do not overexpress hAPP but still develop amyloid pathology to understand the influence of protein overexpression. We also induced tau pathology via human-derived tau seeding material to understand the neurophysiological effects of amyloid and tau pathology. We report that tau-seeded APP-KI animals progressively develop tau pathology, exacerbated by the presence of amyloid pathology. Interestingly, older amyloid-bearing, tau-seeded animals exhibited more amyloid pathology in the entorhinal area, isocortex and hippocampus, but not thalamus, which appeared to correlate with impairments in gamma oscillations before seeding. Tau-seeded animals also featured immediate\u00a0deficits in power spectra values and phase-amplitude indices in the hippocampus after seeding, with gamma power spectra deficits persisting in younger animals. Both deficits in hippocampal phase-amplitude coupling and gamma power differentiate tau-seeded, amyloid-positive animals from buffer controls. Based on our results, impairments in gamma oscillations appear to be strongly associated with the presence and development of amyloid and tau pathology, and may also be an indicator of neuropathology, network dysfunction, and even potential disposition to the future development of amyloid pathology.<\/jats:p>","DOI":"10.1186\/s40478-022-01393-w","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T11:03:11Z","timestamp":1655982191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer\u2019s Disease"],"prefix":"10.1186","volume":"10","author":[{"given":"S.","family":"Tok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Delay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Crauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. V.","family":"Manyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Van Der Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Moechars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-7995","authenticated-orcid":false,"given":"W. H. I. M.","family":"Drinkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","volume":"88","author":"AM Hall","year":"2012","unstructured":"Hall AM, Roberson ED (2012) Mouse models of Alzheimer\u2019s disease. Brain Res Bull 88:3\u201312","journal-title":"Brain Res Bull"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R et al (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7:940\u2013946","journal-title":"EMBO Rep"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351","journal-title":"Neuron"},{"key":"1393_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu L et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7:e31302","journal-title":"PLoS ONE"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/j.1460-2075.1996.tb00468.x","volume":"15","author":"D Moechars","year":"1996","unstructured":"Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F (1996) Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 15:1265\u20131274","journal-title":"EMBO J"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J (2011) Amyloid-\u03b2 and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12:65\u201372","journal-title":"Nat Rev Neurosci"},{"key":"1393_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and Proteolytic Processing of APP. Cold Spring Harb Perspect Med 2:a006270","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M et al (2015) \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526:443\u2013447","journal-title":"Nature"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1523\/JNEUROSCI.1826-18.2019","volume":"39","author":"BG Mockett","year":"2019","unstructured":"Mockett BG et al (2019) Glutamate receptor trafficking and protein synthesis mediate the facilitation of LTP by secreted amyloid precursor protein-alpha. J Neurosci 39:3188\u20133203","journal-title":"J Neurosci"},{"key":"1393_CR12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.25659","volume":"6","author":"PA Pousinha","year":"2017","unstructured":"Pousinha PA et al (2017) Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein. Elife 6:e25659","journal-title":"Elife"},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuropharm.2010.02.011","volume":"59","author":"AD Randall","year":"2010","unstructured":"Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT (2010) The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 59:243\u2013267","journal-title":"Neuropharmacology"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2008.11.005","volume":"33","author":"A-M Sim\u00f3n","year":"2009","unstructured":"Sim\u00f3n A-M et al (2009) Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol Dis 33:369\u2013378","journal-title":"Neurobiol Dis"},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T et al (2014) Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci 17:661\u2013663","journal-title":"Nat Neurosci"},{"key":"1393_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M et al (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature 360:672\u2013674","journal-title":"Nature"},{"key":"1393_CR17","doi-asserted-by":"publisher","first-page":"27081","DOI":"10.1074\/jbc.M111.257378","volume":"286","author":"T Hashimoto","year":"2011","unstructured":"Hashimoto T, Adams KW, Fan Z, McLean PJ, Hyman BT (2011) Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assay. J Biol Chem 286:27081\u201327091","journal-title":"J Biol Chem"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/NEN.0b013e3181c6b84d","volume":"69","author":"C Guardia-Laguarta","year":"2010","unstructured":"Guardia-Laguarta C et al (2010) Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69:53\u201359","journal-title":"J Neuropathol Exp Neurol"},{"key":"1393_CR19","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.96.6.3053","volume":"96","author":"SF Lichtenthaler","year":"1999","unstructured":"Lichtenthaler SF et al (1999) Mechanism of the cleavage specificity of Alzheimer\u2019s disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci USA 96:3053\u20133058","journal-title":"Proc Natl Acad Sci USA"},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1212\/WNL.55.8.1224","volume":"55","author":"M Yasuda","year":"2000","unstructured":"Yasuda M et al (2000) A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation. Neurology 55:1224\u20131227","journal-title":"Neurology"},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.3390\/ijms22116132","volume":"22","author":"A Robert","year":"2021","unstructured":"Robert A, Sch\u00f6ll M, Vogels T (2021) Tau seeding mouse models with patient brain-derived aggregates. Int J Mol Sci 22:6132","journal-title":"Int J Mol Sci"},{"key":"1393_CR22","doi-asserted-by":"publisher","first-page":"6981268","DOI":"10.1155\/2019\/6981268","volume":"2019","author":"A Ahnaou","year":"2019","unstructured":"Ahnaou A, Walsh C, Manyakov NV, Youssef SA, Drinkenburg WH (2019) Early electrophysiological disintegration of hippocampal neural networks in a novel locus coeruleus tau-seeding mouse model of Alzheimer\u2019s disease. Neural Plast 2019:6981268","journal-title":"Neural Plast"},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","volume":"115","author":"J Jeong","year":"2004","unstructured":"Jeong J (2004) EEG dynamics in patients with Alzheimer\u2019s disease. Clin Neurophysiol 115:1490\u20131505","journal-title":"Clin Neurophysiol"},{"key":"1393_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149587","volume":"11","author":"FM Smits","year":"2016","unstructured":"Smits FM et al (2016) Electroencephalographic fractal dimension in healthy ageing and Alzheimer\u2019s disease. PLoS ONE 11:e0149587","journal-title":"PLoS ONE"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z et al (2018) Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29\u201338","journal-title":"Nat Med"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2014.10.010","volume":"159","author":"N Renier","year":"2014","unstructured":"Renier N et al (2014) iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159:896\u2013910","journal-title":"Cell"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prot.24988","volume":"84","author":"TJ Malia","year":"2016","unstructured":"Malia TJ et al (2016) Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8. Proteins 84:427\u2013434","journal-title":"Proteins"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/cb900112v","volume":"4","author":"A \u00c5slund","year":"2009","unstructured":"\u00c5slund A et al (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 4:673\u2013684","journal-title":"ACS Chem Biol"},{"key":"1393_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.cell.2016.05.007","volume":"165","author":"N Renier","year":"2016","unstructured":"Renier N et al (2016) Mapping of brain activity by automated volume analysis of immediate early genes. Cell 165:1789\u20131802","journal-title":"Cell"},{"key":"1393_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.nbd.2019.03.010","volume":"127","author":"JR Detrez","year":"2019","unstructured":"Detrez JR et al (2019) Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain. Neurobiol Dis 127:398\u2013409","journal-title":"Neurobiol Dis"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.celrep.2014.12.014","volume":"10","author":"Y Kim","year":"2015","unstructured":"Kim Y et al (2015) Mapping social behavior-induced brain activation at cellular resolution in the mouse. Cell Rep 10:292\u2013305","journal-title":"Cell Rep"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1109\/TMI.2009.2035616","volume":"29","author":"S Klein","year":"2010","unstructured":"Klein S, Staring M, Murphy K, Viergever MA, Pluim JPW (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196\u2013205","journal-title":"IEEE Trans Med Imaging"},{"key":"1393_CR33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis A et al (2018) DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat Neurosci 21:1281\u20131289","journal-title":"Nat Neurosci"},{"key":"1393_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0014-4886(75)90195-8","volume":"49","author":"R Kramis","year":"1975","unstructured":"Kramis R, Vanderwolf CH, Bland BH (1975) Two types of hippocampal rhythmical slow activity in both the rabbit and the rat: relations to behavior and effects of atropine, diethyl ether, urethane, and pentobarbital. Exp Neurol 49:58\u201385","journal-title":"Exp Neurol"},{"key":"1393_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pbiomolbio.2010.10.004","volume":"105","author":"PJ Uhlhaas","year":"2011","unstructured":"Uhlhaas PJ, Pipa G, Neuenschwander S, Wibral M, Singer W (2011) A new look at gamma? High- (> 60 Hz) \u03b3-band activity in cortical networks: function, mechanisms and impairment. Prog Biophys Mol Biol 105:14\u201328","journal-title":"Prog Biophys Mol Biol"},{"key":"1393_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1109\/TAU.1967.1161901","volume":"15","author":"P Welch","year":"1967","unstructured":"Welch P (1967) The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Audio Electroacoust 15:70\u201373","journal-title":"IEEE Trans Audio Electroacoust"},{"key":"1393_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000343478","volume":"66","author":"M Jobert","year":"2012","unstructured":"Jobert M et al (2012) Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG). Neuropsychobiology 66:201\u2013220","journal-title":"Neuropsychobiology"},{"key":"1393_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1152\/jn.00106.2010","volume":"104","author":"ABL Tort","year":"2010","unstructured":"Tort ABL, Komorowski R, Eichenbaum H, Kopell N (2010) Measuring phase-amplitude coupling between neuronal oscillations of different frequencies. J Neurophysiol 104:1195\u20131210","journal-title":"J Neurophysiol"},{"key":"1393_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0167-2789(88)90081-4","volume":"31","author":"T Higuchi","year":"1988","unstructured":"Higuchi T (1988) Approach to an irregular time series on the basis of the fractal theory. Physica D 31:277\u2013283","journal-title":"Physica D"},{"key":"1393_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cmpb.2016.05.014","volume":"133","author":"S Kesi\u0107","year":"2016","unstructured":"Kesi\u0107 S, Spasi\u0107 SZ (2016) Application of Higuchi\u2019s fractal dimension from basic to clinical neurophysiology: a review. Comput Methods Programs Biomed 133:55\u201370","journal-title":"Comput Methods Programs Biomed"},{"key":"1393_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1196\/annals.1342.054","volume":"1048","author":"S Spasi\u0107","year":"2005","unstructured":"Spasi\u0107 S, Kalauzi A, \u0106uli\u0107 M, Grbi\u0107 G, Marta\u0107 L (2005) Estimation of parameter kmax in fractal analysis of rat brain activity. Ann N Y Acad Sci 1048:427\u2013429","journal-title":"Ann N Y Acad Sci"},{"key":"1393_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167\u2013169","journal-title":"Neurosci Lett"},{"key":"1393_CR43","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1002\/chem.201301463","volume":"19","author":"T Klingstedt","year":"2013","unstructured":"Klingstedt T et al (2013) The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates. Chemistry 19:10179\u201310192","journal-title":"Chemistry"},{"key":"1393_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nan.12197","volume":"41","author":"F Clavaguera","year":"2015","unstructured":"Clavaguera F, Hench J, Goedert M, Tolnay M (2015) Invited review: Prion-like transmission and spreading of tau pathology. Neuropathol Appl Neurobiol 41:47\u201358","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1393_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-018-1953-5","volume":"137","author":"C Vergara","year":"2019","unstructured":"Vergara C et al (2019) Amyloid-\u03b2 pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol 137:397\u2013412","journal-title":"Acta Neuropathol"},{"key":"1393_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh1448","author":"G Meisl","year":"2021","unstructured":"Meisl G et al (2021) In vivo rate-determining steps of tau seed accumulation in Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abh1448","journal-title":"Sci Adv"},{"key":"1393_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnmol.2020.00106","volume":"13","author":"S Houben","year":"2020","unstructured":"Houben S et al (2020) Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta, and tau pathologies in 5XFAD transgenic mice. Front Mol Neurosci 13:106","journal-title":"Front Mol Neurosci"},{"key":"1393_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon A et al (2012) Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73:685\u2013697","journal-title":"Neuron"},{"key":"1393_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2018.00267","volume":"12","author":"SL DeVos","year":"2018","unstructured":"DeVos SL et al (2018) Synaptic tau seeding precedes tau pathology in human Alzheimer\u2019s disease brain. Front Neurosci 12:267","journal-title":"Front Neurosci"},{"key":"1393_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2017.00311","volume":"9","author":"W Hu","year":"2017","unstructured":"Hu W et al (2017) Expression of tau pathology-related proteins in different brain regions: a molecular basis of tau pathogenesis. Front Aging Neurosci 9:311","journal-title":"Front Aging Neurosci"},{"key":"1393_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2020.00011","volume":"12","author":"F Hern\u00e1ndez","year":"2020","unstructured":"Hern\u00e1ndez F, Merch\u00e1n-Rubira J, Vall\u00e9s-Saiz L, Rodr\u00edguez-Matell\u00e1n A, Avila J (2020) Differences between human and murine tau at the N-terminal end. Front Aging Neurosci 12:11","journal-title":"Front Aging Neurosci"},{"key":"1393_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084849","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, G\u00f6tz J (2013) Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS ONE 8:e84849","journal-title":"PLoS ONE"},{"key":"1393_CR53","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jalz.2016.01.014","volume":"12","author":"W Hu","year":"2016","unstructured":"Hu W et al (2016) Hyperphosphorylation determines both the spread and the morphology of tau pathology. Alzheimers Dement 12:1066\u20131077","journal-title":"Alzheimers Dement"},{"key":"1393_CR54","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1038\/s41380-021-01257-0","volume":"26","author":"LE Arroyo-Garc\u00eda","year":"2021","unstructured":"Arroyo-Garc\u00eda LE et al (2021) Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer\u2019s disease. Mol Psychiatry 26:5557\u20135567","journal-title":"Mol Psychiatry"},{"key":"1393_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnsys.2017.00048","volume":"11","author":"T Nakazono","year":"2017","unstructured":"Nakazono T et al (2017) Impaired in vivo gamma oscillations in the medial entorhinal cortex of knock-in Alzheimer model. Front Syst Neurosci 11:48","journal-title":"Front Syst Neurosci"},{"key":"1393_CR56","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.neuron.2020.06.023","volume":"107","author":"H Jun","year":"2020","unstructured":"Jun H et al (2020) Disrupted place cell remapping and impaired grid cells in a knockin model of Alzheimer\u2019s disease. Neuron 107:1095-1112.e6","journal-title":"Neuron"},{"key":"1393_CR57","doi-asserted-by":"publisher","first-page":"dmm040550","DOI":"10.1242\/dmm.040550","volume":"12","author":"E Pervolaraki","year":"2019","unstructured":"Pervolaraki E et al (2019) Insoluble A\u03b2 overexpression in an App knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours. Dis Model Mech 12:dmm040550","journal-title":"Dis Model Mech"},{"key":"1393_CR58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrn3241","volume":"13","author":"G Buzs\u00e1ki","year":"2012","unstructured":"Buzs\u00e1ki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and currents \u2014 EEG, ECoG, LFP and spikes. Nat Rev Neurosci 13:407\u2013420","journal-title":"Nat Rev Neurosci"},{"key":"1393_CR59","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1523\/JNEUROSCI.0962-07.2007","volume":"27","author":"N Axmacher","year":"2007","unstructured":"Axmacher N et al (2007) Sustained neural activity patterns during working memory in the human medial temporal lobe. J Neurosci 27:7807\u20137816","journal-title":"J Neurosci"},{"key":"1393_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn2044","volume":"8","author":"M Bartos","year":"2007","unstructured":"Bartos M, Vida I, Jonas P (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45\u201356","journal-title":"Nat Rev Neurosci"},{"key":"1393_CR61","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 17:777\u2013792","journal-title":"Nat Rev Neurosci"},{"key":"1393_CR62","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L et al (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149:708\u2013721","journal-title":"Cell"},{"key":"1393_CR63","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","volume":"25","author":"S Hijazi","year":"2020","unstructured":"Hijazi S et al (2020) Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease. Mol Psychiatry 25:3380\u20133398","journal-title":"Mol Psychiatry"},{"key":"1393_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fnsys.2021.782399","volume":"15","author":"A Traikapi","year":"2021","unstructured":"Traikapi A, Konstantinou N (2021) Gamma oscillations in Alzheimer\u2019s disease and their potential therapeutic role. Front Syst Neurosci 15:154","journal-title":"Front Syst Neurosci"},{"key":"1393_CR65","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1038\/s41467-019-13260-9","volume":"10","author":"G Etter","year":"2019","unstructured":"Etter G et al (2019) Optogenetic gamma stimulation rescues memory impairments in an Alzheimer\u2019s disease mouse model. Nat Commun 10:5322","journal-title":"Nat Commun"},{"key":"1393_CR66","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF et al (2016) Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540:230\u2013235","journal-title":"Nature"},{"key":"1393_CR67","doi-asserted-by":"publisher","first-page":"782399","DOI":"10.3389\/fnsys.2021.782399","volume":"15","author":"A Traikapi","year":"2021","unstructured":"Traikapi A, Konstantinou N (2021) Gamma oscillations in Alzheimer\u2019s disease and their potential therapeutic role. Front Syst Neurosci 15:782399","journal-title":"Front Syst Neurosci"},{"key":"1393_CR68","first-page":"2740","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani M et al (2018) Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease. Brain 141:2740\u20132754","journal-title":"Brain"},{"key":"1393_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnagi.2017.00194","volume":"9","author":"B Spittau","year":"2017","unstructured":"Spittau B (2017) Aging microglia\u2014phenotypes, functions and implications for age-related neurodegenerative diseases. Front Aging Neurosci 9:194","journal-title":"Front Aging Neurosci"},{"key":"1393_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JAD-2011-101014","volume":"25","author":"AM Floden","year":"2011","unstructured":"Floden AM, Combs CK (2011) Microglia demonstrate age-dependent interaction with amyloid-\u03b2 fibrils. J Alzheimers Dis 25:279\u2013293","journal-title":"J Alzheimers Dis"},{"key":"1393_CR71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12974-018-1347-6","volume":"15","author":"T Blume","year":"2018","unstructured":"Blume T et al (2018) Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo \u03bcPET-study. J Neuroinflammation 15:307","journal-title":"J Neuroinflammation"},{"key":"1393_CR72","doi-asserted-by":"publisher","unstructured":"Lopez-Rodriguez AB et al (2018) Microglial and astrocyte priming in the APP\/PS1 model of Alzheimer\u2019s disease: increased vulnerability to acute inflammation and cognitive deficits. 344218. https:\/\/doi.org\/10.1101\/344218","DOI":"10.1101\/344218"},{"key":"1393_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10:217\u2013224","journal-title":"Nat Rev Neurol"},{"key":"1393_CR74","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.1813562116","volume":"116","author":"T-T Ta","year":"2019","unstructured":"Ta T-T et al (2019) Priming of microglia with IFN-\u03b3 slows neuronal gamma oscillations in situ. Proc Natl Acad Sci USA 116:4637\u20134642","journal-title":"Proc Natl Acad Sci USA"},{"key":"1393_CR75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21037\/atm.2018.04.22","volume":"6","author":"J-W Li","year":"2018","unstructured":"Li J-W, Zong Y, Cao X-P, Tan L, Tan L (2018) Microglial priming in Alzheimer\u2019s disease. Ann Transl Med 6:176","journal-title":"Ann Transl Med"},{"key":"1393_CR76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neuroimage.2015.10.009","volume":"125","author":"L Hammelrath","year":"2016","unstructured":"Hammelrath L et al (2016) Morphological maturation of the mouse brain: an in vivo MRI and histology investigation. Neuroimage 125:144\u2013152","journal-title":"Neuroimage"},{"key":"1393_CR77","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1523\/JNEUROSCI.2842-14.2015","volume":"35","author":"P Regan","year":"2015","unstructured":"Regan P et al (2015) Tau phosphorylation at serine 396 residue is required for hippocampal LTD. J Neurosci 35:4804\u20134812","journal-title":"J Neurosci"},{"key":"1393_CR78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2014","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Perry G, Luna-Mu\u00f1oz J, Acevedo-Aquino MC, Williams S (2014) Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome. Neuropathol Appl Neurobiol 40:121\u2013135","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1393_CR79","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA et al (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science 321:1686\u20131689","journal-title":"Science"},{"key":"1393_CR80","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","volume":"29","author":"R Minkeviciene","year":"2009","unstructured":"Minkeviciene R et al (2009) Amyloid \u03b2-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29:3453\u20133462","journal-title":"J Neurosci"},{"key":"1393_CR81","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/cercor\/bhs105","volume":"23","author":"K Gurevicius","year":"2013","unstructured":"Gurevicius K, Lipponen A, Tanila H (2013) Increased cortical and thalamic excitability in freely moving APPswe\/PS1dE9 mice modeling epileptic activity associated with Alzheimer\u2019s disease. Cereb Cortex 23:1148\u20131158","journal-title":"Cereb Cortex"},{"key":"1393_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","volume":"135","author":"F Schneider","year":"2014","unstructured":"Schneider F, Baldauf K, Wetzel W, Reymann KG (2014) Behavioral and EEG changes in male 5xFAD mice. Physiol Behav 135:25\u201333","journal-title":"Physiol Behav"},{"key":"1393_CR83","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/JAD-2010-100879","volume":"22","author":"A Jyoti","year":"2010","unstructured":"Jyoti A, Plano A, Riedel G, Platt B (2010) EEG, activity, and sleep architecture in a transgenic A\u03b2PP swe\/PSEN1 A246E Alzheimer\u2019s disease mouse. J Alzheimer\u2019s Dis 22:873\u2013887","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1393_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0006-8993(02)02617-3","volume":"943","author":"J Wang","year":"2002","unstructured":"Wang J, Ikonen S, Gurevicius K, van Groen T, Tanila H (2002) Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res 943:181\u2013190","journal-title":"Brain Res"},{"key":"1393_CR85","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A et al (2012) Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74:467\u2013474","journal-title":"Neuron"},{"key":"1393_CR86","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA et al (2013) Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 70:1158\u20131166","journal-title":"JAMA Neurol"},{"key":"1393_CR87","doi-asserted-by":"publisher","first-page":"16363","DOI":"10.1038\/s41598-019-51928-w","volume":"9","author":"S Jacob","year":"2019","unstructured":"Jacob S et al (2019) Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer\u2019s disease pathology. Sci Rep 9:16363","journal-title":"Sci Rep"},{"key":"1393_CR88","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.neuron.2020.06.023","volume":"107","author":"H Jun","year":"2020","unstructured":"Jun H et al (2020) Disrupted place cell remapping and impaired grid cells in knock-in model of Alzheimer\u2019s disease. Neuron 107:1095-1112.e6","journal-title":"Neuron"},{"key":"1393_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche MA et al (2019) Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo. Nat Neurosci 22:57\u201364","journal-title":"Nat Neurosci"},{"key":"1393_CR90","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1038\/s41598-019-48870-2","volume":"9","author":"TTK Munia","year":"2019","unstructured":"Munia TTK, Aviyente S (2019) Time-frequency based phase-amplitude coupling measure for neuronal oscillations. Sci Rep 9:12441","journal-title":"Sci Rep"},{"key":"1393_CR91","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1038\/s41598-017-13839-6","volume":"7","author":"A Ahnaou","year":"2017","unstructured":"Ahnaou A et al (2017) Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer\u2019s disease pathology. Sci Rep 7:14189","journal-title":"Sci Rep"},{"key":"1393_CR92","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fnhum.2016.00238","volume":"10","author":"MMA Engels","year":"2016","unstructured":"Engels MMA et al (2016) Slowing of hippocampal activity correlates with cognitive decline in early onset Alzheimer\u2019s disease. An MEG study with virtual electrodes. Front Human Neurosci 10:238","journal-title":"Front Human Neurosci"},{"key":"1393_CR93","doi-asserted-by":"crossref","unstructured":"Dauwels J et al (2011) Slowing and loss of complexity in Alzheimer\u2019s EEG: two sides of the same coin?","DOI":"10.4061\/2011\/539621"},{"key":"1393_CR94","first-page":"2320","volume":"2017","author":"AH Al-Nuaimi","year":"2017","unstructured":"Al-Nuaimi AH, Jammeh E, Sun L, Ifeachor E (2017) Higuchi fractal dimension of the electroencephalogram as a biomarker for early detection of Alzheimer\u2019s disease. Annu Int Conf IEEE Eng Med Biol Soc 2017:2320\u20132324","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"1393_CR95","doi-asserted-by":"publisher","first-page":"E9318","DOI":"10.3390\/ijms21239318","volume":"21","author":"S Toniolo","year":"2020","unstructured":"Toniolo S, Sen A, Husain M (2020) Modulation of brain hyperexcitability: potential new therapeutic approaches in Alzheimer\u2019s disease. Int J Mol Sci 21:E9318","journal-title":"Int J Mol Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01393-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:16:53Z","timestamp":1655993813000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01393-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01393-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo and in vitro studies were performed in strict accordance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and with the European Council Directive of 24 November 1986 (86\/609\/EEC) and European Ethics Committee directive (2010\/63\/EU) for the protection of laboratory animals. In line with Belgian governmental directives all protocols were approved by the Animal Care and Use Committee of Janssen Pharmaceutica NV.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they are working for Janssen Pharmaceutica NV. The authors declare no other commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}